跳至主要内容
临床试验/NCT00957112
NCT00957112已完成3 期

The Efficacy of Acupuncture and Self-acupuncture in Managing Cancer-related Fatigue in Breast Cancer Patients: a Pragmatic Randomised Trial

University of Manchester1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2007年10月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
320
试验地点
1
主要终点
General fatigue as measured by the Multidimensional Fatigue Inventory

研究概览

简要总结

RATIONALE: Acupuncture may help relieve fatigue caused by breast cancer. It is not yet known whether acupuncture is more effective than self-acupuncture in managing fatigue in women with breast cancer.

PURPOSE: This randomized phase III trial is studying acupuncture to see how well it works compared with self-acupuncture in managing cancer-related fatigue in women who have received chemotherapy for stage I, stage II, or stage IIIA breast cancer.

详细描述

OBJECTIVES:

  • Assess the efficacy of a course of acupuncture in the management of cancer-related fatigue in a homogeneous sample of women with stage I, II, or IIIA breast cancer who have completed adjuvant chemotherapy.
  • Assess the efficacy of self-acupuncture in comparison to therapist-administered acupuncture in sustaining, in the longer term, any effects observed with a 6-week course of acupuncture in these patients.

OUTLINE: This is a multicenter study. Patients are stratified according to study center and fatigue score (low vs moderate vs severe). Patients are randomized at 3:1 ratio (arm I: arm II) to 1 of 2 treatment arms.

  • Arm I (experimental): Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management.
  • Arm II (control): Patients undergo standard care. They also receive written information about fatigue as in arm I.

After 6 weeks, patients in arm I are again randomized to 1 of 3 arms.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Supportive Care
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Diagnosis of breast cancer
  • •Stage I, II, or IIIA disease
  • •Completed prior chemotherapy for ≥ 1 month and up to 5 years
  • •No needling on the ipsilateral arm of patients who have undergone axillary dissection
  • •No needling on the lymphedematous limbs
  • •Score of ≥ 5 on a 0-10 single-item screening fatigue scale, where 0 is no fatigue at all and 10 is extremely fatigued
  • •Hormone receptor status not specified
  • •PATIENT CHARACTERISTICS:
  • •Life expectancy ≥ 6 months
  • •Menopausal status not specified
  • •Platelet count ≥ 50,000/mm^3
  • •Hemoglobin ≥ 10 g/dL
  • •Hematocrit ≥ 30%
  • •Not pregnant
  • •No needle phobia
  • •No co-morbidity with any of the following:
  • •Bleeding disorder
  • •Thyroid dysfunction
  • •PRIOR CONCURRENT THERAPY:
  • •See Disease Characteristics
  • •No planned concurrent chemoradiotherapy
  • •No concurrent steroids
  • •No concurrent epoetin alfa or transfusion for anemia
  • •No other concurrent complementary therapies

排除标准

  • 未提供

研究组 & 干预措施

Arm I

Experimental

Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management.

干预措施: acupuncture therapy (Procedure)

Arm II

No Intervention

Patients receive standard care. They also receive written information about fatigue as in arm I.

干预措施: standard follow-up care (Procedure)

Arm A

Experimental

Patients receive treatment as in arm I for 4 more weeks.

干预措施: acupuncture therapy (Procedure)

Arm B

No Intervention

Patients receive standard care as in arm II for 4 more weeks.

干预措施: standard follow-up care (Procedure)

Arm C

Experimental

Patients learn to self-acupuncture and do so weekly for 4 more weeks.

干预措施: acupuncture therapy (Procedure)

结局指标

主要结局

General fatigue as measured by the Multidimensional Fatigue Inventory

次要结局

  • Mental fatigue as measured by the Multidimensional Fatigue Inventory
  • Anxiety as measured by the Hospital Anxiety and Depression Scale
  • Depression as measured by the Hospital Anxiety and Depression Scale
  • Quality of life as measured by the FACT-G and Breast Cancer module

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验